Search for: "Amgen Inc. v. Sanofi" Results 61 - 80 of 103
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Dec 2022, 7:59 am by Dennis Crouch
Full Scope Enabling Written Description: The court has granted only one petition, Amgen Inc., v. [read post]
2 May 2021, 1:41 pm by Magdaleen Jooste
PatentlyOreported on the case of Amgen Inc. v. [read post]
26 Apr 2024, 12:41 pm by Dennis Crouch
by Dennis Crouch I was rereading the Supreme Court’s recent enablement decision of Amgen Inc. v. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Amgen Inc. and Wyeth (patent infringement) 10/28: Deston Therapeutics LLC, Unigen Pharmaceuticals Inc. v. [read post]
21 Apr 2022, 10:07 am by Dennis Crouch
Scope and Procedure for the Enablement Requirement: Amgen Inc., et al. v. [read post]
17 Oct 2017, 6:09 pm
  Judge Robinson had concluded that the patent was valid, and applied the test articulated in eBay Inc. v. [read post]
7 Sep 2010, 6:10 pm by Kelly
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen,… [read post]
31 Aug 2010, 10:01 pm by Kelly
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
3 Jul 2023, 3:00 am by Jordan Duenckel
Judge Reyna also references the recent Amgen v. [read post]